The Introduction and Inspiration of Risk Evaluation and Mitigation Strategies in the Unite State
LI Shu -fang1, PAN Wen -hao2
1.The Fengtian Hospital of Shenyang Medical University, Liaoning Shenyang 110024, China; 2.The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Liaoning Shenyang 110032, China
LI Shu -fang, PAN Wen -hao. The Introduction and Inspiration of Risk Evaluation and Mitigation Strategies in the Unite State [J]. Chinese Journal of Pharmacovigilance, 2013, 10(5): 283-285.
[1] SFDA.Development and Use of Risk Minimization Action Plans [EB/OL]. [2012-09-01].http://www.fda.gov/downloads/Regulatory Information/Guidances/UC M126830.pdf. [2] ParagonRx.Risk Evaluation and Mitigation Strategies (REMS)-A Brief History[EB/OL].[2009-09-01].http://www.paragonrx.com/rems-hub/rems-history/. [3] American Pharmacists Association.White paper on designing a risk evaluation and mitigation strategies(REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system [EB/OL]. [2009-12-01]. http://www.ncbi.nlm.nih.gov/pubmed/19926553. [4] The Free Library.What every healthcare practitioner needs to know about REMS[EB/OL].[2010-10-01]. http://www.thefreelibrary.com/What+every+healthcare+practitioner+needs+to+know+about+REMS.-a0245169826. [5] SFDA.Approved Risk Evaluation and Mitigation Strategies (REMS)[EB/OL]. [2012-09-18]. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm#Current.
